LH Laboratory Corp Of America Holdings

Price (delayed)

$372.46

Market cap

$30.24B

P/E Ratio

30.36

Dividend/share

$2.88

EPS

$12.27

Enterprise value

$36.76B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 55

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by ...

Highlights
Laboratory Corp Of America Holdings's EPS has increased by 20% YoY
LH's net income is up by 17% YoY
The price to earnings (P/E) is 27% higher than the last 4 quarters average of 23.9 and 19% higher than the 5-year quarterly average of 25.5
The quick ratio has contracted by 20% from the previous quarter and by 8% YoY

Key stats

What are the main financial stats of LH

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
0.06%
1 week
2.52%
1 month
18.05%
1 year
40.02%
YTD
48.46%
QTD
20.89%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$14.59B
Gross profit
$4.23B
Operating income
$1.5B
Net income
$1B
Gross margin
29%
Net margin
6.9%
LH's net income is up by 17% YoY
Laboratory Corp Of America Holdings's operating income has increased by 13% YoY
The net margin has increased by 11% year-on-year
The gross profit has increased by 8% year-on-year and by 2% since the previous quarter

Price vs fundamentals

How does LH's price correlate with its fundamentals

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
30.36
P/B
3.41
P/S
2.07
EV/EBIT
25.28
EV/EBITDA
15.53
EV/Sales
2.52
The price to earnings (P/E) is 27% higher than the last 4 quarters average of 23.9 and 19% higher than the 5-year quarterly average of 25.5
Laboratory Corp Of America Holdings's EPS has increased by 20% YoY
The P/B is 42% higher than the 5-year quarterly average of 2.4 and 31% higher than the last 4 quarters average of 2.6
The company's equity rose by 2.8% QoQ
LH's price to sales (P/S) is 29% higher than its last 4 quarters average of 1.6 and 22% higher than its 5-year quarterly average of 1.7
LH's revenue is up by 6% year-on-year

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA is up by 15% YoY
LH's ROE is up by 13% YoY
The company's return on invested capital rose by 4.2% YoY
Laboratory Corp Of America Holdings's return on sales has increased by 3.1% YoY

Dividends

What is LH's dividend history
DPS
$2.88
Dividend yield
0.77%
Payout ratio
23.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 88% greater than its total liabilities
Laboratory Corp Of America Holdings's current ratio has decreased by 22% from the previous quarter and by 9% YoY
The quick ratio has contracted by 20% from the previous quarter and by 8% YoY
The debt is 23% smaller than the equity
The debt has increased by 3.8% year-on-year
The company's equity rose by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.